Literature DB >> 30926948

Relationships between circulating 25(OH) vitamin D, leptin levels and visceral adipose tissue volume: results from a 1-year lifestyle intervention program in men with visceral obesity.

Anne Gangloff1,2, Jean Bergeron2, Isabelle Lemieux1, Angelo Tremblay1,3, Paul Poirier1,4, Natalie Alméras1,3, Jean-Pierre Després5,6.   

Abstract

BACKGROUND/
OBJECTIVES: Obesity has been associated with elevated leptinemia and vitamin D deficiency. To date, whether there is an association between vitamin D and leptin levels independent from adiposity remains uncertain. Our objective was to investigate the associations between changes in 25(OH) vitamin D levels, changes in adiposity variables, and changes in leptin levels produced by a 1-year lifestyle intervention program. SUBJECTS/
METHODS: Sedentary men (n = 113) with abdominal obesity, dyslipidemic, and non-vitamin D supplemented were involved in a 1-year lifestyle modification program. Subjects were individually counseled by a kinesiologist and a nutritionist once every 2 weeks during the first 4 months with subsequent monthly visits in order to elicit a 500 kcal daily energy deficit and to increase physical activity/exercise habits. Adiposity mapping by computed tomography and cardiometabolic biomarkers, as well as vitamin D measurements were performed at baseline and at the 1-year visit.
RESULTS: The 1-year intervention resulted in a 26% decrease in visceral adipose tissue volume (from 1951 ± 481 to 1463 ± 566 cm3), a 27% decrease in leptin levels (from 12.0 ± 8.1 to 8.5 ± 7.8 ng/mL) and a 27% increase in plasma 25(OH) vitamin D concentrations (from 50 ± 18 to 60 ± 18 nmol/L, p < 0.0001). One-year increases in 25(OH) vitamin D levels were inversely correlated with 1-year changes in leptin levels (r = -0.41, p < 0.001). The association remained significant after adjustment for 1-year changes in various adiposity indices: visceral adipose tissue (r = -0.30, p = 0.0019), subcutaneous adipose tissue (r = -0.35, p = 0.0004), total abdominal adipose tissue (r = -0.31, p = 0.0015), and fat mass (r = -0.31, p = 0.001).
CONCLUSIONS: In response to a 1-year lifestyle intervention, changes in 25(OH) vitamin D levels were independently associated with changes in leptinemia after adjustment for adiposity changes. This finding supports a possible physiological link between leptinemia and 25(OH) vitamin D levels independent from adiposity and underscores the role of lifestyle modifications leading to lowered leptinemia in the clinical management of vitamin D deficiency.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30926948     DOI: 10.1038/s41366-019-0347-7

Source DB:  PubMed          Journal:  Int J Obes (Lond)        ISSN: 0307-0565            Impact factor:   5.095


  34 in total

Review 1.  Body fat distribution and risk of cardiovascular disease: an update.

Authors:  Jean-Pierre Després
Journal:  Circulation       Date:  2012-09-04       Impact factor: 29.690

2.  Association between visceral and subcutaneous adipose depots and incident cardiovascular disease risk factors.

Authors:  Tobin M Abraham; Alison Pedley; Joseph M Massaro; Udo Hoffmann; Caroline S Fox
Journal:  Circulation       Date:  2015-08-20       Impact factor: 29.690

3.  Impact of abdominal visceral and subcutaneous adipose tissue on cardiometabolic risk factors: the Jackson Heart Study.

Authors:  Jiankang Liu; Caroline S Fox; DeMarc A Hickson; Warren D May; Kristen G Hairston; J Jeffery Carr; Herman A Taylor
Journal:  J Clin Endocrinol Metab       Date:  2010-09-15       Impact factor: 5.958

Review 4.  Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism.

Authors:  Paul Poirier; Thomas D Giles; George A Bray; Yuling Hong; Judith S Stern; F Xavier Pi-Sunyer; Robert H Eckel
Journal:  Circulation       Date:  2005-12-27       Impact factor: 29.690

Review 5.  Overview of epidemiology and contribution of obesity to cardiovascular disease.

Authors:  Marjorie Bastien; Paul Poirier; Isabelle Lemieux; Jean-Pierre Després
Journal:  Prog Cardiovasc Dis       Date:  2013-10-24       Impact factor: 8.194

Review 6.  Leptin resistance and diet-induced obesity: central and peripheral actions of leptin.

Authors:  Neira Sáinz; Jaione Barrenetxe; María J Moreno-Aliaga; José Alfredo Martínez
Journal:  Metabolism       Date:  2014-10-23       Impact factor: 8.694

7.  Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects.

Authors:  M Maffei; J Halaas; E Ravussin; R E Pratley; G H Lee; Y Zhang; H Fei; S Kim; R Lallone; S Ranganathan
Journal:  Nat Med       Date:  1995-11       Impact factor: 53.440

Review 8.  Cardiovascular and Metabolic Heterogeneity of Obesity: Clinical Challenges and Implications for Management.

Authors:  Ian J Neeland; Paul Poirier; Jean-Pierre Després
Journal:  Circulation       Date:  2018-03-27       Impact factor: 29.690

9.  Serum immunoreactive-leptin concentrations in normal-weight and obese humans.

Authors:  R V Considine; M K Sinha; M L Heiman; A Kriauciunas; T W Stephens; M R Nyce; J P Ohannesian; C C Marco; L J McKee; T L Bauer
Journal:  N Engl J Med       Date:  1996-02-01       Impact factor: 91.245

Review 10.  Overview of Epidemiology and Contribution of Obesity and Body Fat Distribution to Cardiovascular Disease: An Update.

Authors:  Marie-Eve Piché; Paul Poirier; Isabelle Lemieux; Jean-Pierre Després
Journal:  Prog Cardiovasc Dis       Date:  2018-06-28       Impact factor: 8.194

View more
  4 in total

1.  Multiple Sclerosis: Lipids, Lymphocytes, and Vitamin D.

Authors:  Colleen E Hayes; James M Ntambi
Journal:  Immunometabolism       Date:  2020-05-07

2.  Relationships Between Vitamin D Status and Cytokine: Results from Interferon-Based Therapy in Non-Cirrhotic, Treatment-Naïve Patients with Chronic Hepatitis C Infection.

Authors:  Hsuan-Wei Chen; Yi-Lin Chiu; Tsai-Yuan Hsieh; Peng-Jen Chen; Tien-Yu Huang; Hsuan-Hwai Lin; Yu-Lueng Shih; Jung-Chun Lin
Journal:  J Inflamm Res       Date:  2020-12-29

Review 3.  Vitamin D and Visceral Obesity in Humans: What Should Clinicians Know?

Authors:  Prapimporn Chattranukulchai Shantavasinkul; Hataikarn Nimitphong
Journal:  Nutrients       Date:  2022-07-27       Impact factor: 6.706

4.  Association between anthropometric markers of adiposity, adipokines and vitamin D levels.

Authors:  Pollyanna Patriota; Serge Rezzi; Idris Guessous; Pedro Marques-Vidal
Journal:  Sci Rep       Date:  2022-09-14       Impact factor: 4.996

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.